Jose Saro

676 total citations
6 papers, 41 citations indexed

About

Jose Saro is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Jose Saro has authored 6 papers receiving a total of 41 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Jose Saro's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jose Saro is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jose Saro collaborates with scholars based in Switzerland, Netherlands and Germany. Jose Saro's co-authors include Jan H.M. Schellens, Jean Tessier, C. Willemien Menke‐van der Houven van Oordt, Marc C. Huisman, Emma R. Mulder, Henk M.W. Verheul, Stefan Evers, Tapan K. Nayak, Marcel P. M. Stokkel and Berlinda J. de Wit–van der Veen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Jose Saro

6 papers receiving 40 citations

Peers

Jose Saro

ONCOL

RNMI

MB

IMMUN

GENET

Loes Plaisier Netherlands

Shannon E. Lynch United States

Kristin Vazzana United States

John Srouji United States

Tina Weinzierl Switzerland

Lauren McCarl United States

Maria Dasovich

Jeffrey Eastham United States

Xavier Peyrassol Belgium

Ouiam Bakkacha United States

Loes Plaisier Netherlands

Jose Saro

23 ×0.9

ONCOL

20 ×0.8

RNMI

15 ×1.1

MB

24 ×1.7

IMMUN

2 ×0.5

GENET

Citations per year, relative to Jose Saro Jose Saro (= 1×) peers Loes Plaisier

Countries citing papers authored by Jose Saro

Since Specialization

Citations

This map shows the geographic impact of Jose Saro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jose Saro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jose Saro more than expected).

Fields of papers citing papers by Jose Saro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jose Saro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jose Saro. The network helps show where Jose Saro may publish in the future.

Co-authorship network of co-authors of Jose Saro

This figure shows the co-authorship network connecting the top 25 collaborators of Jose Saro. A scholar is included among the top collaborators of Jose Saro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jose Saro. Jose Saro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Brummelen, Emilie M.J. van, Marc C. Huisman, Berlinda J. de Wit–van der Veen, et al.. (2018). 89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding. Oncotarget. 9(37). 24737–24749. 25 indexed citations

2.

Brummelen, Emilie M.J. van, Tapan K. Nayak, Marc C. Huisman, et al.. (2016). 89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation in a dose-dependent manner and role of IL-2 receptor-binding. Annals of Oncology. 27. vi114–vi114. 3 indexed citations

3.

Nicolini, Valeria, Inja Waldhauer, Anne Freimoser–Grundschober, et al.. (2016). Abstract 2217: Combining CEA-IL2v and FAP-IL2v immunocytokines with PD-L1 checkpoint blockade. Cancer Research. 76(14_Supplement). 2217–2217. 4 indexed citations

4.

Bacac, Marina, Tanja Fauti, Sara Colombetti, et al.. (2015). Abstract 2481: CEA TCB, a novel T-cell bispecific antibody with potent in vitro and in vivo antitumor activity against solid tumors. Cancer Research. 75(15_Supplement). 2481–2481. 1 indexed citations

5.

Bacac, Marina, Tanja Fauti, Sara Colombetti, et al.. (2015). ITOC2 – 037. CEA TCB, A novel T-cell bispecific antibody with potent in vitro and in vivo antitumour activity against solid tumours. European Journal of Cancer. 51. S13–S13. 1 indexed citations

6.

Glen, Hilary, David S. Boss, T. R. J. Evans, et al.. (2007). A phase I dose finding study of E7080 in patients (pts) with advanced malignancies. Journal of Clinical Oncology. 25(18_suppl). 14073–14073. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact